InMed Pharmaceuticals Inc.
INM
$1.51
-$0.02-1.31%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.17% | 102.23% | 66.61% | 68.10% | -38.24% |
| Total Receivables | -- | -30.31% | 20.65% | 31.83% | 77.08% |
| Inventory | -- | -14.09% | -26.99% | -22.75% | -31.83% |
| Prepaid Expenses | 21.52% | 2.53% | 28.81% | -32.66% | -50.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.46% | 60.67% | 48.35% | 48.08% | -36.31% |
|
|
|||||
| Total Current Assets | 7.46% | 60.67% | 48.35% | 48.08% | -36.31% |
| Net Property, Plant & Equipment | -42.01% | -37.91% | -34.36% | -20.62% | -19.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.79% | -9.56% | -9.33% | -9.12% | -8.92% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.40% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -1.57% | 31.63% | 27.67% | 31.78% | -30.53% |
|
|
|||||
| Total Accounts Payable | -59.79% | -70.97% | -17.80% | -40.90% | 39.05% |
| Total Accrued Expenses | -7.06% | -11.05% | 5.65% | 4.72% | 16.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.27% | -2.76% | 0.12% | 37.04% | 24.23% |
| Total Finance Division Other Current Liabilities | 21,800.00% | 1,586.18% | 8,340.00% | -98.29% | -93.22% |
| Total Other Current Liabilities | 21,800.00% | 1,586.18% | 8,340.00% | -98.29% | -93.22% |
| Total Current Liabilities | 20.24% | -17.36% | 8.29% | -6.69% | 20.29% |
|
|
|||||
| Total Current Liabilities | 20.24% | -17.36% | 8.29% | -6.69% | 20.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -92.65% | -76.61% | -66.00% | -52.58% | -42.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.72% | -30.88% | -14.46% | -18.01% | 0.19% |
|
|
|||||
| Common Stock & APIC | 6.85% | 9.27% | 9.58% | 10.49% | 3.58% |
| Retained Earnings | -7.37% | -6.76% | -7.41% | -7.48% | -7.76% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -1.85% | 55.09% | 38.06% | 45.93% | -36.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.85% | 55.09% | 38.06% | 45.93% | -36.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.85% | 55.09% | 38.06% | 45.93% | -36.77% |
|
|
|||||